Location History:
- Vinderhoute, BE (1995)
- Ghent, BE (2001 - 2003)
- Vinderhouse, BE (2004)
Company Filing History:
2 out of 130 
1 out of 44 
1 out of 1 Years Active: 1995-2004
Title: Inventor Spotlight: Erik R Remaut
Introduction
Erik R Remaut is a notable inventor based in Vinderhoute, Belgium. With a remarkable portfolio that includes five patents, he has significantly contributed to the fields of biotechnology and medicine, particularly in the realms of cytokine therapy and delivery systems.
Latest Patents
Among his latest innovations, Erik is credited with two notable patents. The first patent addresses the "Use of a cytokine-producing lactococcus strain to treat colitis." This invention focuses on an administration strategy that aims to deliver cytokines or cytokine antagonists, specifically acid-sensitive anti-inflammatory agents like IL-10 and/or soluble TNF receptors, via the oral route. The process entails inoculating patients with a suspension of recombinant cells engineered to produce these crucial proteins.
His second recent patent involves the "Delivery of biologically active polypeptides." This patent outlines a method to administer biologically active polypeptides and/or antigens using a non-invasive or non-pathogenic bacterium that expresses these substances. These bacteria can be encapsulated in pharmaceutical formulations or delivery systems, improving the therapeutic efficacy of vaccines and treatments.
Career Highlights
Throughout his career, Erik has made significant strides in the biotech industry, having worked for prestigious companies like Biogen, Inc. His professional journey reflects his commitment to advancing medical science through innovative biotechnology solutions.
Collaborations
Erik has collaborated with prominent figures in the research community, including Lothar Steidler and Walter C Fiers. These partnerships have fostered the development of groundbreaking technologies that hold the potential to transform patient care in various medical fields.
Conclusion
Erik R Remaut's contributions to biotechnology, particularly in cytokine production and delivery systems, underscore his importance as an inventor in the field. With his ongoing research and patented innovations, he continues to pave the way for future advancements that could enhance therapeutic methods and patient outcomes globally.